QuidelOrtho
QDEL
$85.14
Share price
-1.56%
Change (1 day)
-10.41%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.
Revenue for QuidelOrtho (QDEL)
Revenue in 2023 (TTM): $3.10 B
According to QuidelOrtho's latest financial reports the company's current revenue (TTM) is $3.10 B. In 2022 the company made a revenue of $3.26 B an increase over the years 2021 revenue that were of $1.69 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for QuidelOrtho from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $3.10 B | -4.78% |
| 2022 | $3.26 B | 92.28% |
| 2021 | $1.69 B | 2.22% |
| 2020 | $1.66 B | 210.66% |
| 2019 | $0.53 B | 2.41% |
| 2018 | $0.52 B | 88.05% |
| 2017 | $0.27 B | 44.96% |
| 2016 | $0.19 B | -1.94% |
| 2015 | $0.19 B | 7% |
| 2014 | $0.18 B | 4.11% |
| 2013 | $0.17 B | 12.63% |
| 2012 | $0.15 B | -1.8% |
| 2011 | $0.15 B | 39.94% |
| 2010 | $0.11 B | -31.01% |
| 2009 | $0.16 B | 28.21% |
| 2008 | $0.12 B | 8.53% |
| 2007 | $0.11 B | 11.37% |
| 2006 | $0.10 B | 14.86% |
| 2005 | $92.29 M | 17.29% |
| 2004 | $78.69 M | -17.26% |
| 2003 | $95.1 M | 24.69% |
| 2002 | $76.27 M | 4.21% |
| 2001 | $73.18 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $43.80 B | 1,308.68% | 🇺🇸 USA |
 Becton Dickinson BDX | $18.80 B | 504.83% | 🇺🇸 USA |
 Danaher DHR | $30.95 B | 895.24% | 🇺🇸 USA |
 PerkinElmer
PKI | $3.35 B | 7.96% | 🇺🇸 USA |
 OraSure Technologies OSUR | $0.38 B | -87.54% | 🇺🇸 USA |
 Meridian Bioscience VIVO | $0.33 B | -89.29% | 🇺🇸 USA |